Mersana Therapeutics Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 04:20PM GMT
Alec Warren Stranahan - BofA Securities, Research Division - Associate

Hey, everyone. Good morning, and welcome to day 2 of the 2023 BofA Healthcare Conference. Thanks for joining this session with Mersana. My name is Alec Stranahan, I'm Vice President and Senior Biotech Analyst at BofA. And I'm pleased to be joined by Anna Protopapas, President and Chief Executive Officer of Mersana as well as Mohan Bala, Senior Vice President and Strategic Product Planning Program Leadership at Mersana. Thanks for joining, guys.

Anna Protopapas - Mersana Therapeutics, Inc. - President, CEO & Director

Well, thanks for having us.

Questions and Answers:

Alec Warren Stranahan - BofA Securities, Research Division - Associate

Great. So we're just going to jump into Q&A. We've got 15 minutes. But if anyone in the audience has a question, feel free just to raise your hand throughout, and we'll bring you a mic and you can ask your question. But Anna, maybe just to start for those newer to the story, could you give us an
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot